Skip to main content
Clinical Trials/NCT05079191
NCT05079191UnknownNot Applicable

Diagnostic Performance and Predictive Impact of the CT Scan in Patients With Suspected Covid-19

University Hospital, Strasbourg, France1 site in 1 country2,000 target enrollmentStarted: June 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
2,000
Locations
1
Primary Endpoint
Retrospective study of the chest scanner in suspected Covid-19

Study Overview

Brief Summary

The diagnostic performance of the scanner in the indication of suspected Covid-19 is not yet well known, especially in comparison with the results of RT-PCR.

The potential use of the scanner as a tool for quantifying the severity of Covid-19 disease is not yet well established, especially the variations between readers or between measurement techniques.

The impact of the scanner in predicting the fate of patients with confirmed Covid-19 is not yet known.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Retrospective study of the chest scanner in suspected Covid-19

Time Frame: Files analysed retrospectively from March 01, 2020 to April 29, 2020 will be examined]

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Impact of the CT Scan in Patients With... | Clinical Trial